CORMEDIX INC - LDO CUSTOMER BEGINS IMPLEMENTATION OF DEFENCATH
CORMEDIX INC - EXPECTS MODEST REVENUE CONTRIBUTION IN JUNE
CORMEDIX INC - INCREASES Q2 NET SALES GUIDANCE TO $35MM-$40MM
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.